The study further showed that MAST4 is a negative regulator of MMBD and that the levels of MAST4 in MM cells negatively correlate with the severity of MMBD; high estrogen pathway activation levels correlated with high levels of MAST4 [30]. The gene discussed is MAST4; the disease is Miyoshi myopathy.